↓ Skip to main content

Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats

Overview of attention for article published in Neurotherapeutics, July 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
54 Mendeley
Title
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats
Published in
Neurotherapeutics, July 2019
DOI 10.1007/s13311-019-00723-6
Pubmed ID
Authors

Henning J Drews, Konstantin Yenkoyan, Ali Lourhmati, Marine Buadze, Daniela Kabisch, Stephan Verleysdonk, Stefan Petschak, Sandra Beer-Hammer, Tigran Davtyan, William H Frey, Christoph H Gleiter, Matthias Schwab, Lusine Danielyan

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 17%
Student > Master 8 15%
Other 6 11%
Student > Bachelor 6 11%
Professor 3 6%
Other 6 11%
Unknown 16 30%
Readers by discipline Count As %
Medicine and Dentistry 11 20%
Neuroscience 7 13%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Agricultural and Biological Sciences 3 6%
Nursing and Health Professions 3 6%
Other 7 13%
Unknown 18 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 March 2019.
All research outputs
#3,276,501
of 25,385,509 outputs
Outputs from Neurotherapeutics
#327
of 1,308 outputs
Outputs of similar age
#65,526
of 363,724 outputs
Outputs of similar age from Neurotherapeutics
#10
of 25 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,308 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,724 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.